Back to Results
First PageMeta Content
American Association for Cancer Research / Protein kinase inhibitor / Display board / Academia / Poster session / Serine/threonine-specific protein kinase


SuperGen PIM Kinase Presentations at AACR DUBLIN, Calif., Mar 31, 2011 (BUSINESS WIRE) -SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today a
Add to Reading List

Open Document

File Size: 11,88 KB

Share Result on Facebook
UPDATE